Search research articles
Contact Us
Filters
Showing results (31-40 of 40) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 40 results.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
April 9, 2025
Respiratory syncytial virus hospitalisation burden in children below 18 years in six European countries (2016-2023) pre- and post-COVID-19 pandemic
Ombeline Jollivet, Arantxa Urchueguía-Fornes, Kocfa Chung-Delgado, et al.
The Pediatric Infectious Disease Journal
|
November 26, 2024
Impact of Nirsevimab on Respiratory Syncytial Virus Bronchiolitis in Hospitalized Infants: A Real-World Study
Eric Jeziorski, Antoine Ouziel, Marie Cotillon, et al.
Infection
|
February 19, 2025
RSV is the main cause of severe respiratory infections in infants and young children in Germany - data from the prospective, multicenter PAPI study 2021-2023
Martin Wetzke, Matthias Lange, Cordula Koerner-Rettberg, et al.
The Lancet. Respiratory Medicine
|
January 12, 2025
Burden of RSV infections among young children in primary care: a prospective cohort study in five European countries (2021-23)
Sarah F Hak, Valérie D V Sankatsing, Joanne G Wildenbeest, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|
December 19, 2019
Extensively drug-resistant <i>Klebsiella pneumoniae</i> ST307 outbreak, north-eastern Germany, June to October 2019
Sebastian Haller, Rolf Kramer, Karsten Becker, et al.
The Journal of Infection
|
April 7, 2024
Change in Age profile of Respiratory Syncytial Virus disease over the course of annual epidemics: a multi-national study
Saverio Caini, Jean-Sebastien Casalegno, Ana Paula Rodrigues, et al.
Human Vaccines & Immunotherapeutics
|
May 13, 2024
Assessment of effectiveness and impact of universal prophylaxis with nirsevimab for prevention of hospitalizations due to respiratory syncytial virus in infants. The NIRSE-GAL study protocol
Narmeen Mallah, Sonia Ares-Gómez, Jacobo Pardo-Seco, et al.
European Journal of Pediatrics
|
May 2, 2025
Respiratory syncytial virus-related lower respiratory tract infection hospitalizations in infants receiving nirsevimab in Galicia (Spain): the NIRSE-GAL study
Angela Manzanares, Jacobo Pardo-Seco, Irene Rivero-Calle, et al.
The Lancet. Infectious Diseases
|
May 3, 2024
Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study
Sonia Ares-Gómez, Narmeen Mallah, María-Isolina Santiago-Pérez, et al.
The Lancet. Infectious Diseases
|
January 15, 2026
Impact of universal nirsevimab prophylaxis in infants on hospital and primary care outcomes across two respiratory syncytial virus seasons in Galicia, Spain (NIRSE-GAL): a population-based prospective observational study
Josefina L Razzini, Iago Giné-Vázquez, Jing Jin, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 40) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 40 results.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
April 9, 2025
Respiratory syncytial virus hospitalisation burden in children below 18 years in six European countries (2016-2023) pre- and post-COVID-19 pandemic
Ombeline Jollivet, Arantxa Urchueguía-Fornes, Kocfa Chung-Delgado, et al.
The Pediatric Infectious Disease Journal
|
November 26, 2024
Impact of Nirsevimab on Respiratory Syncytial Virus Bronchiolitis in Hospitalized Infants: A Real-World Study
Eric Jeziorski, Antoine Ouziel, Marie Cotillon, et al.
Infection
|
February 19, 2025
RSV is the main cause of severe respiratory infections in infants and young children in Germany - data from the prospective, multicenter PAPI study 2021-2023
Martin Wetzke, Matthias Lange, Cordula Koerner-Rettberg, et al.
The Lancet. Respiratory Medicine
|
January 12, 2025
Burden of RSV infections among young children in primary care: a prospective cohort study in five European countries (2021-23)
Sarah F Hak, Valérie D V Sankatsing, Joanne G Wildenbeest, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|
December 19, 2019
Extensively drug-resistant <i>Klebsiella pneumoniae</i> ST307 outbreak, north-eastern Germany, June to October 2019
Sebastian Haller, Rolf Kramer, Karsten Becker, et al.
The Journal of Infection
|
April 7, 2024
Change in Age profile of Respiratory Syncytial Virus disease over the course of annual epidemics: a multi-national study
Saverio Caini, Jean-Sebastien Casalegno, Ana Paula Rodrigues, et al.
Human Vaccines & Immunotherapeutics
|
May 13, 2024
Assessment of effectiveness and impact of universal prophylaxis with nirsevimab for prevention of hospitalizations due to respiratory syncytial virus in infants. The NIRSE-GAL study protocol
Narmeen Mallah, Sonia Ares-Gómez, Jacobo Pardo-Seco, et al.
European Journal of Pediatrics
|
May 2, 2025
Respiratory syncytial virus-related lower respiratory tract infection hospitalizations in infants receiving nirsevimab in Galicia (Spain): the NIRSE-GAL study
Angela Manzanares, Jacobo Pardo-Seco, Irene Rivero-Calle, et al.
The Lancet. Infectious Diseases
|
May 3, 2024
Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study
Sonia Ares-Gómez, Narmeen Mallah, María-Isolina Santiago-Pérez, et al.
The Lancet. Infectious Diseases
|
January 15, 2026
Impact of universal nirsevimab prophylaxis in infants on hospital and primary care outcomes across two respiratory syncytial virus seasons in Galicia, Spain (NIRSE-GAL): a population-based prospective observational study
Josefina L Razzini, Iago Giné-Vázquez, Jing Jin, et al.
Page
of 4